Clinical Trial Site
Lucerne 6000
1 studies enrolling now · 2 studies all time
What they study most
High Cardiovascular Risk, Hypertension, Transthyretin Amyloidosis With Cardiomyopathy
Studies at this site
- TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
- Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed